| Feasibility of neurofilament light chain as a blood-based biomarker for screening across neurological diseases B Cameron, A Patel, B Cobb, I Suridjan, N Win Journal of the Neurological Sciences 455, 121474, 2023 | | 2023 |
| The potential clinical value of plasma biomarkers in Alzheimer's disease K Blennow, D Galasko, R Perneczky, FC Quevenco, WM van der Flier, ... Alzheimer's & Dementia 19 (12), 5805-5816, 2023 | 10 | 2023 |
| CSF markers YKL40, sTREM2, and a‐synuclein enhance the Alzheimer’s disease A/T/N criteria to detect early changes in cognition R Canovas, CJ Fowler, QX Li, SR Rainey‐Smith, M Carboni, I Suridjan, ... Alzheimer's & Dementia 19, e082891, 2023 | | 2023 |
| Brain‐age prediction and its associations with glial and synaptic CSF markers I Cumplido‐Mayoral, M Milà‐Alomà, C Falcon, R Cacciaglia, C Minguillon, ... Alzheimer's & Dementia 19, e078194, 2023 | 1 | 2023 |
| Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease DJ Panyard, J McKetney, YK Deming, AR Morrow, GE Ennis, EM Jonaitis, ... Alzheimer's & Dementia 19 (12), 5447-5470, 2023 | 13* | 2023 |
| Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study MB Heston, KL Hanslik, KR Zarbock, SJ Harding, NJ Davenport-Sis, ... Scientific Reports 13 (1), 18924, 2023 | 8 | 2023 |
| Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT (N) framework: defining abnormal neurodegeneration and improving prediction of clinical status RL Gallagher, RL Koscik, JF Moody, NM Vogt, N Adluru, SR Kecskemeti, ... Alzheimer's Research & Therapy 15 (1), 180, 2023 | 4 | 2023 |
| Blood‐based biomarkers in Alzheimer's disease: Future directions for implementation I Suridjan, WM van der Flier, AU Monsch, N Burnie, R Baldor, M Sabbagh, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (4 …, 2023 | | 2023 |
| Prevalence and clinical implications of a β-Amyloid–negative, tau-positive cerebrospinal fluid biomarker profile in Alzheimer disease P Erickson, J Simrén, WS Brum, GE Ennis, G Kollmorgen, I Suridjan, ... JAMA neurology 80 (9), 969-979, 2023 | 9 | 2023 |
| CSF metabolites associated with biomarkers of Alzheimer’s disease pathology R Dong, Q Lu, H Kang, I Suridjan, G Kollmorgen, N Wild, Y Deming, ... Frontiers in Aging Neuroscience 15, 1214932, 2023 | 5 | 2023 |
| Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk Y Deming, E Vasiljevic, A Morrow, J Miao, C Van Hulle, E Jonaitis, Y Ma, ... Alzheimer's & Dementia 19 (8), 3406-3416, 2023 | 5 | 2023 |
| The AD Workbench NeuroToolKit Application (NTKApp) suite of cloud-based tools for secure collaborative research in Alzheimer’s disease C Logan, M Carboni, A Bauer, S Bentik, E Rosenfeld, A Maxim, R Tomsa, ... Alzheimer's Association International Conference, 2023 | 1 | 2023 |
| Improving statistical modeling with a neuropathology‐based APOE genetic risk score Y Deming, E Vasiljevic, J Miao, CA Van Hulle, EM Jonaitis, AR Morrow, ... Alzheimer's & Dementia 19, e060701, 2023 | | 2023 |
| Cerebrospinal fluid soluble TREM2 is associated with accelerated AD‐related longitudinal neurodegeneration in preclinical Alzheimer’s disease HG Stephenson, Y Deming, M Ewers, Y Ma, CA Van Hulle, RL Koscik, ... Alzheimer's & Dementia 19, e068312, 2023 | | 2023 |
| Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting Alzheimer’s disease pathology R Dong, DN Denier-Fields, CA Van Hulle, G Kollmorgen, I Suridjan, ... European journal of epidemiology 38 (5), 559-571, 2023 | 3 | 2023 |
| Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases (P10-6.002) B Cameron, A Patel, B Cobb, I Suridjan, N Win Neurology 100 (17_supplement_2), 1522, 2023 | | 2023 |
| Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s Disease and neurodegeneration … I Cumplido-Mayoral, M García-Prat, G Operto, C Falcon, M Shekari, ... Elife 12, e81067, 2023 | 15 | 2023 |
| Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease C Kurz, L Stöckl, I Schrurs, I Suridjan, SÜ Gürsel, T Bittner, A Jethwa, ... Journal of Neurochemistry 165 (1), 95-105, 2023 | 9 | 2023 |
| Clinical performance and robustness evaluation of plasma amyloid‐β42/40 prescreening C Rabe, T Bittner, A Jethwa, I Suridjan, E Manuilova, M Friesenhahn, ... Alzheimer's & Dementia 19 (4), 1393-1402, 2023 | 26 | 2023 |
| An accurate fully automated panel of plasma biomarkers for Alzheimer's disease S Palmqvist, E Stomrud, N Cullen, S Janelidze, E Manuilova, A Jethwa, ... Alzheimer's & Dementia 19 (4), 1204-1215, 2023 | 74 | 2023 |
